ALGN vs AZN: fair value comparison
Align Technology, Inc. and AstraZeneca PLC · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, AZN currently sits closer to the top of our discount ranking.
| ALGN | AZN | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $158.63 | $156.93 |
| 12-month range | $137.88–$189.02 | $156.93–$202.39 |
| Sector rank | #10 of 113 Healthcare | #6 of 113 Healthcare |
| Quality grade | B | B |
| Leverage | Low | Moderate |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| DCF cross-check | Overvalued | Undervalued |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: ALGN fair value analysis · AZN fair value analysis